| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ski1
kowska21 Dept of Internal Medicine and Hypertension, Medical University of Warsaw, and 2 Dept of Chest Medicine, Institute of Lung Diseases and Tuberculosis, Warsaw, Poland
CORRESPONDENCE: P. Pruszczyk, Dept of Internal Medicine and Hypertension, Medical University of Warsaw, Banacha 1a, 02-097, Warsaw, Poland. Fax: 48 226593373. E-mail: piotr.pruszczyk@amwaw.edu.pl
Keywords: brain natriuretic peptide, echocardiography, mortality, pulmonary embolism, right ventricle
Received: March 2, 2003
Accepted May 14, 2003
Plasma brain natriuretic peptide (BNP), released from myocytes of ventricles upon stretch, has been reported to differentiate pulmonary from cardiac dyspnoea. Limited data have shown elevated plasma BNP levels in acute pulmonary embolism (APE), frequently accompanied by dyspnoea and right ventricular (RV) dysfunction. The aim of this study was to assess plasma N-terminal proBNP (NT-proBNP) in APE, and to establish whether it reflects the severity of RV overload and if it can be used to predict adverse clinical outcome.
On admission, NT-proBNP and echocardiography for RV overload were performed in 79 APE patients (29 males), aged 63±16 yrs.
Plasma NT-proBNP was elevated in 66 patients (83.5%) and was higher in patients with (median 4,650 pg·mL–1 (range 61–60,958)) than without RV strain (363 pg·mL–1 (16–16,329)). RV-to-left ventricular ratio and inferior vena cava dimension correlated with NT-proBNP. All 15 in-hospital deaths and 24 serious adverse events occurred in the group with elevated NT-proBNP, while all 13 (16.5%) patients with normal values had an uncomplicated clinical course. Plasma NT-proBNP predicted in-hospital mortality.
Plasma N-terminal pro-brain natriuretic peptide is elevated in the majority of cases of pulmonary embolism resulting in right ventricular overload. Plasma levels reflect the degree of right ventricular overload and may help to predict short-term outcome. Acute pulmonary embolism should be considered in the differential diagnosis of patients with dyspnoea and abnormal levels of brain natriuretic peptide.
This article has been cited by other articles:
|
|
 |
|
  Authors/Task Force Members, A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, P. Pruszczyk, F. Bengel, A. J.B. Brady, D. Ferreira, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur. Heart J., September 2, 2008; 29(18): 2276 - 2315. [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Klok, I. C. M. Mos, and M. V. Huisman Brain-Type Natriuretic Peptide Levels in the Prediction of Adverse Outcome in Patients with Pulmonary Embolism: A Systematic Review and Meta-analysis Am. J. Respir. Crit. Care Med., August 15, 2008; 178(4): 425 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Sanchez, L. Trinquart, I. Colombet, P. Durieux, M. V. Huisman, G. Chatellier, and G. Meyer Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review Eur. Heart J., June 2, 2008; 29(12): 1569 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lankeit, T. Kempf, C. Dellas, M. Cuny, H. Tapken, T. Peter, M. Olschewski, S. Konstantinides, and K. C. Wollert Growth Differentiation Factor-15 for Prognostic Assessment of Patients with Acute Pulmonary Embolism Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 1018 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.H. Wilson Tang, G. S. Francis, D. A. Morrow, L. K. Newby, C. P. Cannon, R. L. Jesse, A. B. Storrow, R. H. Christenson, COMMITTEE MEMBERS, R. H. Christenson, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure Circulation, July 31, 2007; 116(5): e99 - e109. [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Carlbom and B. L. Davidson Pulmonary Embolism in the Critically Ill Chest, July 1, 2007; 132(1): 313 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kostrubiec, A. Kaczynska, and P. Pruszczyk Risk assessment in acute pulmonary embolism Eur. Heart J., June 1, 2006; 27(11): 1384 - 1384. [Full Text] [PDF]
|
|
|
|
|
|
A. Fijalkowska, M. Kurzyna, A. Torbicki, G. Szewczyk, M. Florczyk, P. Pruszczyk, and M. Szturmowicz Serum N-Terminal Brain Natriuretic Peptide as a Prognostic Parameter in Patients With Pulmonary Hypertension Chest, May 1, 2006; 129(5): 1313 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Januzzi Jr, R. Sakhuja, M. O'Donoghue, A. L. Baggish, S. Anwaruddin, C. U. Chae, R. Cameron, D. G. Krauser, R. Tung, C. A. Camargo Jr, et al. Utility of amino-terminal pro-brain natriuretic Peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med, February 13, 2006; 166(3): 315 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Clerico, F. A. Recchia, C. Passino, and M. Emdin Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H17 - H29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Giannakoulas, A. Hatzitolios, H. Karvounis, G. Koliakos, A. Charitandi, T. Dimitroulas, C. Savopoulos, E. Tsirogianni, and G. Louridas N-Terminal Pro-Brain Natriuretic Peptide Levels Are Elevated in Patients with Acute Ischemic Stroke Angiology, November 1, 2005; 56(6): 723 - 730. [Abstract] [PDF]
|
|
|
|
|
|
M. Kostrubiec, P. Pruszczyk, A. Bochowicz, R. Pacho, M. Szulc, A. Kaczynska, G. Styczynski, A. Kuch-Wocial, P. Abramczyk, Z. Bartoszewicz, et al. Biomarker-based risk assessment model in acute pulmonary embolism Eur. Heart J., October 2, 2005; 26(20): 2166 - 2172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Giannitsis and H. A. Katus Risk Stratification in Pulmonary Embolism Based on Biomarkers and Echocardiography Circulation, September 13, 2005; 112(11): 1520 - 1521. [Full Text] [PDF]
|
|
|
|
|
|
L. Binder, B. Pieske, M. Olschewski, A. Geibel, B. Klostermann, C. Reiner, and S. Konstantinides N-Terminal Pro-Brain Natriuretic Peptide or Troponin Testing Followed by Echocardiography for Risk Stratification of Acute Pulmonary Embolism Circulation, September 13, 2005; 112(11): 1573 - 1579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Piazza and S. Z. Goldhaber The Acutely Decompensated Right Ventricle: Pathways for Diagnosis and Management Chest, September 1, 2005; 128(3): 1836 - 1852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Yap, D. Mukerjee, P. M. Timms, H. Ashrafian, and J. G. Coghlan Natriuretic Peptides, Respiratory Disease, and the Right Heart Chest, October 1, 2004; 126(4): 1330 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Pruszczyk, M Szulc, and M Kostrubiec Potential clinical application of brain natriuretic peptides in acute pulmonary embolism Eur. Heart J., April 1, 2004; 25(7): 621 - 621. [Full Text] [PDF]
|
|
|
|
|
|
N. Kucher and S. Z. Goldhaber Cardiac Biomarkers for Risk Stratification of Patients With Acute Pulmonary Embolism Circulation, November 4, 2003; 108(18): 2191 - 2194. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
